p53 in epidermoid cancer of the esophagus

Citation
M. Tanaka et al., p53 in epidermoid cancer of the esophagus, HEP-GASTRO, 46(27), 1999, pp. 1765-1768
Citations number
21
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
HEPATO-GASTROENTEROLOGY
ISSN journal
01726390 → ACNP
Volume
46
Issue
27
Year of publication
1999
Pages
1765 - 1768
Database
ISI
SICI code
0172-6390(199905/06)46:27<1765:PIECOT>2.0.ZU;2-3
Abstract
BACKGROUND/AIMS: Wild type p53 protein has an inhibitory effect on cell pro liferation and transformation. Mutation or deletion of the p53 gene can be the first point of malignancy, Abnormalities of the p53 protein gene have b een linked with tumors of the esophagus. METHODOLOGY: In this study, we investigated the expression of the p53 gene in epidermoid carcinoma of the esophagus as well as in the basal layer near the tumor. We studied the expression of p53 in 24 esophageal tumors and in normal esophageal tissue near the tumor in 16 cases, using an immunohistoc hemical reaction. RESULTS: p53 Was positive in 18 esophageal tumors (75%) and in 15 of the 16 (94%) normal samples of esophageal tissue. There was no correlation betwee n expression of the p53 gene and age, sex, tobacco intake, alcoholism, and familiar history of cancer or clinical stage of the disease. The mean survi val of the p53 patients (negative or positive) was similar. CONCLUSIONS: p53 Accumulation was found in most cases of esophageal cancer as well as in samples of normal tissue close to the tumor. The positivity o f p53 seems to be independent of clinical or pathological parameters and wa s not of any use in predicting prognosis in our study.